Sanchez Production Partners LP (SPP)

Sanchez Production Partners LP (SPP) Financial specialists of Sanchez Production Partners LP (SPP) are heading into second half of this current year trusting that the 6 month downtrend will switch itself. Over the past half year shares are down – 22.83% over that time span. All the more as of late the stock is 0.77% in the course of the last 5 exchanging days. Watching somewhat farther the stock is 0.48% for the month and 2.06% for the quarter. Its outstanding shares are at 58,580,870, while authorized share are standing around 150,000,000. At the session level, shares of Sanchez Production […]

Sonde Resources Corp Is Bankrupt Now

Sonde Resources Corp Is Bankrupt Now Sonde Resources Corp as of late declared that it has recorded an intentional task in liquidation compliant with the arrangements of the Bankruptcy and Insolvency Act (Canada). Since 2012, Sonde has been seeking after choices for the Joint Oil Block. Most as of late, in March of 2014, Sonde reported that it had drawn in Taylor-DeJongh, Inc. (“Taylor-DeJongh”) to start a procedure to investigate and assess potential vital other options to upgrade shareholder esteem with respect to the Joint Oil Block. Sonde’s Management and Taylor-DeJongh have effectively sought after all prospects and alternatives accessible […]

Penn West is Expanding its Production Guidance

Penn West is Expanding its Production Guidance At the point when Penn West discharged its most recent quarterly results, the organization announced that it will build its capital costs for 2016 to $90 million, which is twice its recent spending plan. Besides, West has additionally reported that it will burn through $150 million as capital costs one year from now. The organization has gotten consolation to help its spending on the back of the effectiveness of the benefits that stay after its most recent divestiture moves. Its outstanding shares are at 502,163, while authorized share are standing around 260 million. […]

Magellan Petroleum Corporation (NASDAQ: MPET)

Magellan Petroleum Corporation (NASDAQ: MPET) After somewhat over a year of investigating vital choices, Magellan Petroleum Corporation (NASDAQ: MPET) has reported arrangements to converge with a secretly held LNG organization called Tellurian Investments. The organizations are planning to finish the consolidation procedure before the end of this current year and the joined element is relied upon to go up against another name. Magellan Petroleum Corporation, through its wholly owned subsidiary, Magellan Petroleum Australia Limited, and its 100% controlling interest in Nautilus Poplar LLC, is engaged in the sale of oil and gas and the exploration for and development of oil […]

Kodiak Energy is Acquired by Whiting Petroleum

Kodiak Energy is Acquired by Whiting Petroleum Whiting Petroleum’s WLL – 5.31% now-finished takeover of Kodiak Oil and Gas is unrealistic to make any main 10 records in arrangement making this year, given a half dive in both organizations’ shares since merger was reported. In any case, the arrangement is not as awful as stock graphs demonstrate, and it absolutely could have been more regrettable as the cost of oil fell by a third amid the time it took to close the merger. Denver-construct Whiting’s planning in light of its Kodiak procurement has turned out to be heartbreaking, however the […]

Lucas Energy, Inc. (LEI)

Lucas Energy, Inc. (LEI) Lucas Energy, Inc. (LEI) is a free oil and common gas organization. The Company is occupied with the procurement and advancement of unrefined petroleum and characteristic gas from different known beneficial land developments, including the Austin Chalk and Eagle Ford arrangements, fundamentally in Gonzales, Wilson and Karnes Counties, south of the city of San Antonio, Texas. Its outstanding shares are at 1,739,397, while authorized share are standing around 100,000,000. The Company had leasehold interests (working interests) in roughly 8,395 gross sections of land or 8,309 net sections of land. Its aggregate net created and undeveloped real […]

Sucampo Pharmaceuticals (NASDAQ:SCMP)

Sucampo Pharmaceuticals (NASDAQ:SCMP) Sucampo Pharmaceuticals (NASDAQ:SCMP) is a worldwide biopharmaceutical organization essentially centered around the innovative work (R&D) of medications. Its principle item, AMITIZA, is the main chloride channel activator produced for the treatment of endless blockage. It may not be the sexiest item, but rather the best medications once in a while are. Since 2006, AMITIZA, otherwise called lubiprostone, has been administered more than 10 million times. As of now, it is accessible as a little oral gelcap taken twice per day and is endorsed for three signs that spread unmistakable patient sorts: unending idiopathic obstruction (CIC), fractious inside […]

Ivanhoe Energy is Bankrupt Now

Ivanhoe Energy is Bankrupt Now Ivanhoe Energy Inc is a free global overwhelming oil improvement and generation organization. The Company’s center operations are in Canada, Ecuador, China and Mongolia. Operations in Latin American are led through Ivanhoe Energy Latin America Inc., and exercises in China and Southeast Asia are worked by Sunwing Energy Ltd. (Sunwing). In Canada, the Company’s claims the Tamarack Project. In Ecuador, it incorporates the Pungarayacu Project. On December 12 Ivanhoe Energy educated the business sector that it doesn’t hope to meet its advantage commitments on its convertible debenture, and expressed that “Without opportune access to extra […]

Skyline (NASDAQ:SKLN)

Skyline (NASDAQ:SKLN) Skyline (NASDAQ:SKLN) recently reported \that it was expanding its unit trade offering. This offering from January permits financial specialists who acquired the more established, August 2015, units to trade those units for recently offered units. In August, Skyline raised $19M by offering 1,666,667 units with every unit comprising of one offer of normal stock, one Series B convertible offer and four Series A warrants. The Series A warrants are exercisable at $4.95/share furthermore incorporated a “cashless” change highlight. The more up to date units’ Series B warrants had generously comparative components to the old Series A warrants however […]

Provectus Biopharmaceuticals (PVCT)

Provectus Biopharmaceuticals (PVCT) Meagerly exchanged nano cap Provectus Biopharmaceuticals (PVCT) droops on a 4x surge in volume in light of the evaluating of its “earnest attempts” public equity offering. The organization is putting forth 240K shares of Series B Convertible Preferred Stock, at first convertible into a total of 24M shares of regular stock, and warrants to buy up to 24M shares of basic at a cost of $25 for a blend of one Series B offer and one quickly exercisable five-year warrant to buy one offer of basic at $0.275. In the event that effective, gross proceeds will be […]

Progenics (NASDAQ:PGNX)

Progenics (NASDAQ:PGNX) Progenics (NASDAQ:PGNX) reported Q2 EPS and incomes in front of perspectives, and it was not because of superior to anything expected Relistor sovereignties. The organization perceived a $4 million point of reference installment from Bayer (OTCPK:BAYRY) for the PSMA Antibody Technology permit. This cooperation could open some shareholder esteem in the next years. News broke a week ago that Relistor is drawing some purchaser interest and that Valeant (NYSE:VRX) may offer its rights to the most noteworthy bidder. A $400-500 million sticker price was specified in the Bloomberg article. The inferred cost allots little esteem to Relistor considering […]

Pieris Pharmaceuticals Inc. (PIRS:NASDAQ)

Pieris Pharmaceuticals Inc. (PIRS:NASDAQ) Pieris Pharmaceuticals Inc. (PIRS:NASDAQ) was initially a German-based organization emerging from exploration done on some novel proteins. They framed in 2001, and have stretched into numerous sickness signs: oncology, iron deficiency, asthma, ophthalmology, and irresistible illness. Coming from Technical University of Munich (TUM) through Dr. Arne Skerra’s work, Pieris was conceived. They are as of now transitioning into a move to be headquartered in the U.S. from Germany. We’ll go into this later, however we trust this is to stay away from rivalry in Europe. With a business sector top of simply over $65 million USD, […]

Pain Therapeutics is a Solid Pick in Biotech Industry

Pain Therapeutics is a Solid Pick in Biotech Industry Pain Therapeutics is working in the biotech and pharmaceutical industry, having a business sector capitalization of $116.69 million. Opioid misuse is a developing pestilence, and the weight is on to grow better manhandle impediment definitions. Torment Therapeutics is creating two such items, one oral and the other a patch. The present share price is $2.55, which places it in penny stock domain (under $5.00). In this manner, the dangers connected with penny stocks and low market capitalizations ought to be considered. Financial specialists who comprehend the dangers ought to consider this […]

Palatin Technologies Inc. (PTN)

Palatin Technologies Inc. (PTN) Palatin Technologies Inc. (PTN ) has been moving recently as the stock has ascended by 19% in the previous four weeks, and it is as of now exchanging great over its 20-Day SMA. This is a really strong move higher, yet the inquiry that must be on speculators’ brains at this moment is; would this be able to pattern proceed? While there can be no telling without a doubt, it is unquestionably reassuring that profit gauges have ascended in the previous couple of weeks on the organization, proposing that estimation on PTN is moving in the […]

Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM)

Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) It’s been an unpleasant year for Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) shareholders. PPHM slammed on 2/26/2016 when the organization’s Phase III trial for Bavituximab (an exploratory hostile to malignancy medication) was ended. Be that as it may, things were not all fate and unhappiness. Another bio-producing office was commisioned on 3/17/2016. While Bavituximab may have hit a deadlock, the Avid Bioservices division is blasting. The new plant dramatically increased Avid’s assembling limit. The uplifting news for the Avid Bioservices division proceeded with financial Q4 2016 results. Devoted reported a $68 million income overabundance. Fabricating incomes of $50 […]

Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)

Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) An oral insulin tablet could tackle, however for a long time, no organization has made sense of how to even hypothetically regulate insulin orally. That is, as of recently. Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) has demonstrated on a basic level through a late Phase II concentrate on that insulin can be taken orally in the right plan, and lowers evening time pooled glucose contrasted and fake treatment, at any rate as indicated by one trial. A bigger Phase III study will need to affirm these discoveries and is at present being arranged, however the essential confirmation is […]

Northwest Biotherapeutics (NWBO)

Northwest Biotherapeutics (NWBO) Following a decline of 9.3% amid Northwest Biotherapeutics (NWBO) facilitates all things considered volume in light of its revelation that it reduced the activity costs for certain warrant holders as an instigation to bring ~$1.3M up in new capital. The organization offered an activity cost of $0.35 an offer for warrants to buy up to 3,656,817 shares of normal stock with unique activity costs of $4.50 – 6.00. What’s more, Northwest issued new five-year Series E Warrants to the same warrant holders to buy up to 3,656,817 shares of basic stock at $0.41 an offer. However, the […]

Ocular Therapeutics Continues to Surge despite Headwinds

Ocular Therapeutics Continues to Surge despite Headwinds Ocular Therapeutics is up 34.8% recently subsequent to declaring that the FDA’s worries with respect to the organization’s New Drug Application (NDA) seem to have been tended to. Situated in Bedford, MA, OCUL is a biopharmaceutical organization that spotlights on the improvement and commercialization of eye-consideration items. It has created DEXTENZA, a treatment intended to be directed for visual agony taking after eye-related surgery. The FDA issued a Complete Response Letter (CRL) to the organization’s NDA, refering to worries about insufficiencies in OCUL’s assembling forms that were seen amid an assessment. However there […]

Neuralstem, Inc. (Nasdaq:CUR)

Neuralstem, Inc. (Nasdaq:CUR) Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical organization concentrated on the advancement of focal sensory system treatments in light of its neural undifferentiated organism innovation, reported its money related results and gave business and clinical overhauls to the three and six months time spans finished June 30, 2016. In the second quarter of 2016, the organization have taken measures to enhance the Company’s cost structure and finished activities to fortify the association, especially with the arrangement of another Scientific Policy Committee. In Q2, the organization carried clinical headways with its lead compound, NSI-189, and they are satisfied with movement […]

MiMedx Group Inc (MDXG)

MiMedx Group Inc (MDXG) MiMedx Group Inc (MDXG) shares exchanged higher after the organization reported strong growth in its second quarter and increased its full year guidance. The organization said that in light of the quarter-to-date comes about, it sees income between $62 million and $64 million for the second from last quarter. Examiners gauge $63.12 million income. The organization communicated the certainty that the new item dispatches like OrthoFlo would empower it to accomplish the upper end of the income estimate. For the entire year, MiMedx emphasized its direction of $243.5–$248 million with final quarter income to be exceptionally […]